Cite
Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin.
MLA
Kalaska, Bartlomiej, et al. “Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin.” PLoS ONE, vol. 10, no. 3, Mar. 2015, pp. 1–21. EBSCOhost, https://doi.org/10.1371/journal.pone.0119486.
APA
Kalaska, B., Kaminski, K., Sokolowska, E., Czaplicki, D., Kujdowicz, M., Stalinska, K., Bereta, J., Szczubialka, K., Pawlak, D., Nowakowska, M., & Mogielnicki, A. (2015). Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin. PLoS ONE, 10(3), 1–21. https://doi.org/10.1371/journal.pone.0119486
Chicago
Kalaska, Bartlomiej, Kamil Kaminski, Emilia Sokolowska, Dominik Czaplicki, Monika Kujdowicz, Krystyna Stalinska, Joanna Bereta, et al. 2015. “Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin.” PLoS ONE 10 (3): 1–21. doi:10.1371/journal.pone.0119486.